Compare UBS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBS | ABT |
|---|---|---|
| Founded | 1862 | 1888 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.1B | 152.9B |
| IPO Year | 2014 | 2006 |
| Metric | UBS | ABT |
|---|---|---|
| Price | $48.97 | $88.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 20 |
| Target Price | $60.30 | ★ $130.90 |
| AVG Volume (30 Days) | 2.2M | ★ 8.8M |
| Earning Date | 04-29-2026 | 04-16-2026 |
| Dividend Yield | 1.29% | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $7.40 | $10.75 |
| Revenue Next Year | $2.83 | $8.10 |
| P/E Ratio | ★ $17.22 | $146.97 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $30.39 | $81.97 |
| 52 Week High | $49.36 | $137.49 |
| Indicator | UBS | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 63.20 | 45.15 |
| Support Level | $46.47 | $84.96 |
| Resistance Level | $49.36 | $89.34 |
| Average True Range (ATR) | 0.80 | 1.83 |
| MACD | -0.08 | 0.51 |
| Stochastic Oscillator | 97.82 | 34.75 |
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.